MAM
NXTC icon

Marquette Asset Management’s NextCure NXTC Stock Holding History

Marquette Asset Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,855
Closed -$44.9K – 186
2024
Q4 		$44.9K Hold
4,855
– – 0.01% 153
2024
Q3 		$79.8K Hold
4,855
– – 0.01% 148
2024
Q2 		$92.6K Hold
4,855
– – 0.02% 114
2024
Q1 		$130K Hold
4,855
– – 0.02% 96
2023
Q4 		$66.4K Buy
+4,855
New +$70.4K 0.01% 136
2023
Q2 		– Sell
-4,285
Closed -$76.1K – 301
2023
Q1 		$76.1K Buy
+4,285
New +$82.5K 0.02% 128
2022
Q1 		– Sell
-1,458
Closed -$105K – 381
2021
Q4 		$105K Buy
+1,458
New +$122K 0.02% 147

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marquette Asset Management's NXTC Position: Q1 2025 in Review

Marquette Asset Management sold out of NextCure (NXTC) in Q1 2025, closing a stake of 4,855 shares — an estimated $44.9K sold.

Marquette Asset Management first reported a position in NXTC in Q4 2021 and held it in 7 quarters. The position peaked at $130K in Q1 2024. 38 funds tracked by Wall St. Rank hold NXTC as of Q1 2025.

  • Marquette Asset Management reported no remaining NextCure position as of Q1 2025 after selling out during the quarter.
  • Marquette Asset Management sold 4,855 NextCure shares in Q1 2025, an estimated $44.9K.
  • Marquette Asset Management first reported a position in NextCure in Q4 2021 and held it in 7 quarters.
  • Marquette Asset Management's NextCure position peaked at $130K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held NextCure as of Q1 2025.

Based on Marquette Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.